Ibrance 75 MG tablet 7S
Ended Awarded Last action
- Contract number
- SPE2DR26FV943
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,807
Award facts
- Contract value 100% obligated
- $42,807.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $42,807.05 by the Defense Logistics Agency on January 30, 2026, for the supply of Ibrance 75 mg tablets (7-unit quantity). The contract utilizes a firm fixed-price structure with no set-aside designation, indicating the award resulted from full and open competition. This delivery order is issued under Cencora, Inc.'s (AmerisourceBergen's parent company) larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. That IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
This award supports the Defense Logistics Agency's medical supply chain operations, which provide critical pharmaceuticals to military treatment facilities, the Defense Health Agency, the U.S. Coast Guard, and other federal healthcare systems. Ibrance is a brand-name oncology medication used in cancer treatment, exemplifying the specialized pharmaceutical products that AmerisourceBergen delivers through its federal contract portfolio. The delivery order is scheduled for completion by February 23, 2026, with performance occurring at the company's corporate office location in Conshohocken, Pennsylvania.
Quick answers
Who was awarded contract SPE2DR26FV943?
SPE2DR26FV943 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FV943 worth?
The government has obligated $42,807 on SPE2DR26FV943.
Is contract SPE2DR26FV943 an order under another contract?
Yes. SPE2DR26FV943 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV943 competed?
The extent of competition for SPE2DR26FV943 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award